Clinical trial

A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and…

NCT00052039 · InterMune, Industry · Terminated

Key facts

NCT number NCT00052039
Title A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone
Official title A Randomized, Double-Blind, Three-Arm, Phase IIIb Study Comparing the Safety and Efficacy of Interferon Gamma-1b Alone, IFN-Gamma 1b With Azathioprine, and Azathioprine Alone in Patients With Idiopathic Pulmonary Fibrosis Receiving Prednisone
Lead sponsor InterMune, Industry
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Lung Disease, Pulmonary Fibrosis
Intervention type Drug
Interventions interferon-gamma 1b, azathioprine
Enrollment 0
Start date Apr 1, 2002
Completion Jun 1, 2002
First posted Jan 22, 2003
Last update posted Nov 6, 2007
Countries Italy

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies